BeOne Medicines
ONC
#652
Rank
C$54.54 B
Marketcap
C$482.19
Share price
-2.07%
Change (1 day)
5.36%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Quarterly Reports

Thumbnail BeOne Medicines Quarterly Report 2026-q2

Quarterly Report 2026-q2

Language: English

View Quarterly Report
Thumbnail BeOne Medicines Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail BeOne Medicines Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail BeOne Medicines Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report